China's drugmakers can't sell mRNA shots but haven't quit yet

SHANGHAI — China's vaccine developers stuck with unused mRNA Covid shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies — Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics — came up with mRNA vaccines that won limited emergency approvals...

Related Keywords

Australia ,Beijing ,China ,Indonesia ,Malaysia ,Shanghai ,Laos ,Malaysian ,Chinese ,Robert Langer ,Ying Bo ,Kongxay Phounphenghack ,Abogen Biosciences ,Li Hangwen ,Frank Zhang ,Stemirna Covid ,Dicky Budiman ,George Gao ,Davone Duangdany ,Reuters ,Child Health Center ,Chinese Academy Of Sciences Institute Microbiology ,Chinese Center ,Griffith University ,World Health Organisation ,Walvax Biotechnology ,Stemirna Therapeutics ,Chinese Academy ,Sciences Institute ,Chinese Center For Disease Control ,Malaysia Pharmaniaga ,